1466 — Baijin Life Science Holdings Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Baijin Life Science Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	C2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	34.5	24.4	23.6	41.3	37.9
Net Total Accounts Receivable
Net Total Receivables	73.4	39.2	26.6	7.44	30.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	142	90	79.6	98.9	121
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.5	1.75	2.55	0.979	8.78
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	159	91.8	82.1	99.9	197
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	67.3	45.5	45.5	21.1	41
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	73.5	45.8	46.2	21.6	100
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	85.1	45.9	35.9	78.3	96.3
Total Liabilities & Shareholders' Equity	159	91.8	82.1	99.9	197
Total Common Shares Outstanding